These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6765524)

  • 1. Clinical pharmacologic studies with human insulin (recombinant DNA).
    Galloway JA; Root MA; Bergstrom R; Spradlin CT; Howey DC; Fineberg SE; Jackson RL
    Diabetes Care; 1982; 5 Suppl 2():13-22. PubMed ID: 6765524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of human insulin (recombinant DNA)--regular, NPH, and mixtures--obtained by the Gerritzen method in healthy volunteers.
    Weinges K; Ehrhardt M; Nell G; Enzmann F
    Diabetes Care; 1982; 5 Suppl 2():67-70. PubMed ID: 6765545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals.
    Sailer D; Ludwig T; Kolb S
    Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of human insulin of recombinant DNA origin in healthy volunteers.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Tarui S
    Diabetes Care; 1982; 5 Suppl 2():35-8. PubMed ID: 6765537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T
    Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.
    Galloway JA; Spradlin CT; Nelson RL; Wentworth SM; Davidson JA; Swarner JL
    Diabetes Care; 1981; 4(3):366-76. PubMed ID: 7047113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique.
    Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A
    Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins.
    Galloway JA; Spradlin CT; Root MA; Fineberg SE
    Diabetes Care; 1981; 4(2):183-8. PubMed ID: 7011723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
    Heine RJ; Bilo HJ; Fonk T; van der Veen EA; van der Meer J
    Diabetologia; 1984 Dec; 27(6):558-62. PubMed ID: 6397384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
    Kemmer FW; Sonnenberg G; Cüppers HJ; Berger M
    Diabetes Care; 1982; 5 Suppl 2():23-8. PubMed ID: 6765535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men.
    Pickup JC; Bilous RW; Viberti GC; Keen H; Jarrett RJ; Glynne A; Cauldwell J; Root M; Rubenstein AH
    Diabetes Care; 1982; 5 Suppl 2():29-34. PubMed ID: 6765536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO; Hans A; Henning VS
    Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin.
    Viberti GC; Pickup JC; Keen H; Bilous RW; Mattock M; Jarrett RJ; Glynne A; Rogers R
    Diabetes Care; 1981; 4(2):175-9. PubMed ID: 7011721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics and glucodynamics of two human insulin mixtures. 70/30 and 50/50 insulin mixtures.
    Woodworth JR; Howey DC; Bowsher RR; Brunelle RL; Rowe HM; Compton J; Cerimele B
    Diabetes Care; 1994 May; 17(5):366-71. PubMed ID: 8062601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
    Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
    Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different counterregulatory responses to human insulin (recombinant DNA) and purified pork insulin.
    Schlüter KJ; Petersen KG; Sontheimer J; Enzmann F; Kerp L
    Diabetes Care; 1982; 5 Suppl 2():78-81. PubMed ID: 6765547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report.
    Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB
    Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man.
    Rosak C; Althoff PH; Enzmann F; Schöffling K
    Diabetes Care; 1982; 5 Suppl 2():82-9. PubMed ID: 6765548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The U.S. "new patient" and "transfer" studies.
    Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J
    Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.